Edit |   |
---|---|
Antigenic Specificity | PCSK9, Human (Ralpancizumab biosimilar) |
Clone | Ralpancizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human PCSK9 Recombinant Antibody (Ralpancizumab). Ralpancizumab (INN, development code RN317) is a monoclonal antibody designed for the treatment of dyslipidemia. |
Immunogen | n/a |
Other Names | Anti-PCSK9 Recombinant Antibody, Research Grade Ralpancizumab, Anti-Human PCSK9 Recombinant Antibody(Ralpancizumab), PF-05335810, RN317, Antibody Drug Analogues, Monoclonal Antibody, YR1326, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1407495-04-8 |
Catalog # | YR1326 |
Price | please inquire |
Order / More Info | PCSK9, Human (Ralpancizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |